Guardant Health Archives - Inside Precision Medicine

Inside Precision Medicine Guardant’s Liquid Biopsy Test for CRC Gets FDA Nod

Colon cancer. Cancer attacking cell. Colon disease concept

Molecular Dx

Guardant’s Liquid Biopsy Test for CRC Gets FDA Nod

August 7, 2024

News & Features

10 Leading Specialists in Comprehensive Genomic Profiling

Jonathan Smith

February 6, 2024

Molecular Dx

MRD: The Future Foundation of Solid Tumor Trials

Laura Cowen

April 8, 2022

Five-Year Super Successes in Genomics and Precision Medicine

News & Features

Five-Year Super Successes in Genomics and Precision Medicine

Alex Philippidis

March 27, 2019

Projections for the growth of the liquid biopsy market range as low as $1 billion by 2020

Molecular Dx

10 Liquid Biopsy Companies in the Money

Alex Philippidis

March 22, 2017

Related Content

FDA Clears Sangamo’s ST-503 for Chronic Neuropathic Pain Clinical Trials

FDA Clears Sangamo’s ST-503 for Chronic Neuropathic Pain Clinical Trials

Two Key Studies Add to Evidence That Certain Oils Cause Cancer

Two Key Studies Add to Evidence That Certain Oils Cause Cancer

MRI Technique Detects Pre-Malignant Pancreatic Cancer Lesions

MRI Technique Detects Pre-Malignant Pancreatic Cancer Lesions

Early-Onset Colorectal Cancer Rates Are Rising Globally, Study Finds

Early-Onset Colorectal Cancer Rates Are Rising Globally, Study Finds